China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Think tanks and universities have helped expose problematic Chinese business practices. Now, those businesses are accusing ...

Tommy Hilfiger and Calvin Klein owner PVH (PVH) and biotechnology company Illumina (ILMN) were among the first casualties on ...

China announced on Tuesday the inclusion of two US enterprises - clothing company PVH Group and biotechnology company ...

A recent report from Stifel showed that 30% of licensing deals from big pharma companies now involve a Chinese biotech.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

U.S. lawmakers and industry leaders are intensifying calls for stricter export controls to prevent American biopharmaceutical companies from collaborating with China military on biotechnology ...